⌘K

Home/Filings/4/0001209191-23-029609

4//SEC Filing

Alland Leila 4

Accession 0001209191-23-029609

CIK 0001699382other

View on SEC.gov Company Profile

Filed

May 14, 8:00 PM ET

Accepted

May 15, 6:14 PM ET

Size

5.3 KB

Accession

0001209191-23-029609

Insider Transaction Report

Form 4

Period: 2023-05-12

PMV Pharmaceuticals, Inc.PMVP

Chief Medical Officer

Transactions

Award
Employee Stock Option (right to buy)
2023-05-12+100,000→ 100,000 total
Exercise: $5.70Exp: 2033-05-12→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PMV Pharmaceuticals, Inc.

CIK 0001699382

Entity typeother

Related Parties

1

filerCIK 0001825216

Filing Metadata

Form type: 4
Filed: May 14, 8:00 PM ET
Accepted: May 15, 6:14 PM ET
Size: 5.3 KB

View on SEC.gov